Market Trends of Medical Linear Accelerator Industry
Intensity Modulated Radiation Therapy Segment is Expected to Exhibit Significant Growth Over the Forecast Period
Intensity-modulated radiotherapy (IMRT) is an advanced radiation therapy technique that uses medical linear accelerators for the precise targeting and optimization of radiation doses to tumor sites to improve treatment outlook and reduce side effects.
Factors such as improved treatment outcomes with intensity-modulated radiotherapy (IMRT), growing demand for advanced radiation therapy, and the significant role of IMRT in managing several cancers are projected to accelerate industry growth over the forecast period.
The higher dose specificity and reduced risk of toxicity associated with intensity-modulated radiotherapy (IMRT) are expected to accelerate their adoption for cancer management. For instance, according to an article published by Radiation and Environmental Biophysics in December 2022, IMRT delivers a specified dose of radiation to a cancer target even in complex cases and has a lower risk of developing radiation-induced toxicity. Thus, the significance associated with IMRT is anticipated to bolster segment uptake over the forecast period.
Moreover, the long-term benefits of IMRT on cancer patients are further expected to fuel segment growth. For instance, according to September 2023 data from MD Anderson Cancer Center, the IMRT offers long-term benefits in treating patients with locally advanced non-small cell lung cancer (NSCLC) and has lower toxicity issues.
In addition, the crucial role of IMRT in cervical cancer is further projected to augment their adoption over the coming years. For instance, according to September 2022 data from MJH Life Sciences, IMRT is considered a standard therapy in women with cervical endometrial cancer. Thus, such advantages associated with IMRT are expected to foster its uptake in clinical settings over the study period.
Thus, the above-mentioned factors like improved treatment outcomes with intensity-modulated radiotherapy (IMRT), growing demand for advanced radiation therapy, and the significant role of IMRT in the management of several cancers are expected to fuel market growth over the study period.
North America is Expected to Hold a Significant Share in the Market and is Expected to Witness High Growth Over the Study Period
North America is expected to witness robust growth opportunities in the medical linear accelerator market amid factors such as the growing burden of cancer in the region, increasing demand for radiation therapy, growing funding and grants, and several strategic initiatives undertaken by industry participants.
The alarming increase in the burden of cancer in the region is expected to accelerate demand for radiation therapy, which in turn is projected to foster the demand for medical linear accelerator systems. For instance, according to the Canadian Cancer Society, the number of cancer cases ramped from 239 thousand in 2023, and around 247 thousand people are expected to be diagnosed with cancer in Canada in 2024. Thus, the growing burden of cancer in the country is expected to boost market growth over the forecast period.
Moreover, the growing funding/grants to facilitate the development and launch of newer medical linear accelerators in the country are further anticipated to propel market growth over the projection period. For instance, in March 2024 the MJ Murdock Charitable Trust granted funding of USD 400 thousand to Jefferson Healthcare Foundation for the purchase of a linear accelerator (LINAC) cancer radiation treatment machine. Similarly, in March 2024 the Kahlert Foundation donated USD 2.5 million to the Carroll Hospital Foundation to purchase a new medical linear accelerator at its hospital. Thus, such activities are expected to promote the uptake of linear accelerators, which in turn likely to boost market growth over the study period.
Furthermore, several recent developments undertaken in the region are expected to augment industry growth in the region. For instance, in October 2023, Washington State University installed a new linear accelerator to provide advanced radiation therapy to the animals at the veterinary teaching hospital. Thus, such developments are projected to boost regional market growth over the study period.
Thus, the above mentioned factors such as, higher burden of cancer, growing funding activities, and several new installations of medical linear accelerators in the region is expected to accelerate regional market growth over study period.
